Mанитол Биофарм (Mannitol)

Mannitol, the active ingredient in Mанитол Биофарм, is an osmotic diuretic presented as an injectable solution for intravenous use. It reduces intracranial pressure and promotes diuresis in patients with acute renal failure, toxin exposure, or cerebral edema.

GNH USA supplies Mанитол Биофарм as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Mannitol is employed in clinical situations where rapid osmotic diuresis or reduction of tissue water is required.

Intracranial hypertension: lowers intracranial pressure to protect brain tissue. Acute renal failure: increases urine output to aid fluid removal and improve renal clearance. Toxin exposure: enhances renal excretion of nephrotoxic substances, facilitating detoxification.

Mannitol may cause a range of adverse reactions, from mild to severe, depending on patient condition and dosing.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea: occasional upset stomach. - Vomiting: transient episodes. - Electrolyte imbalance: especially hypokalemia. - Dehydration: due to increased urine output. - Transient hypotension: mild blood pressure drop.

Serious or Rare Side Effects: - Severe electrolyte disturbances: hypernatremia or profound hypokalemia. - Worsening renal failure: in patients with pre‑existing kidney impairment. - Pulmonary edema: fluid overload in susceptible individuals. - Anaphylactoid reaction: rare hypersensitivity response. - Hemolysis: extremely rare but reported in isolated cases.

Mannitol administration requires careful clinical monitoring to minimize risks.

Renal function: assess baseline creatinine and glomerular filtration rate. Electrolytes: monitor serum sodium and potassium levels before and during therapy. Fluid balance: avoid excessive volume depletion, especially in dehydrated patients. Cardiac status: use cautiously in heart failure or unstable hemodynamics. Pregnancy: consider only when potential benefit justifies potential risk. Store at ambient temperature: keep in original container, protect from light and moisture.

Mannitol can interact with several drug classes, influencing fluid and electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: additive diuretic effect may cause severe dehydration. - Insulin: hyperosmolar state can exacerbate hyperglycemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: combined use may increase risk of renal impairment. - Lithium: altered renal clearance can raise lithium levels. - Antihypertensives: additive hypotensive effect may require dose adjustment.